IM CannabisIMCC
About: IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
Employees: 95
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
11% more funds holding
Funds holding: 9 [Q3] → 10 (+1) [Q4]
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
2.09% less ownership
Funds ownership: 6.0% [Q3] → 3.91% (-2.09%) [Q4]
10% less capital invested
Capital invested by funds: $316K [Q3] → $284K (-$31.9K) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for IMCC.
Financial journalist opinion









